寶信軟件(600845.SH):河北寶宣擬啓動寶之華北基地A4A5A6樓項目 總投資約17.43億元
格隆匯4月25日丨寶信軟件(600845.SH)公佈,2021年5月公司合資設立控股子公司河北寶宣數據科技有限公司(稱“河北寶宣”),旨在充分利用張家口地區區位優勢,推進寶之雲全國佈局。2024年9月河北寶宣中標某數據中心項目,目前正在推進A1、A2樓數據中心項目建設。根據合同相關條款約定,河北寶宣擬啓動寶之華北基地A4A5A6樓項目。項目總投資約17.43億元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.